Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Nanomedicine. 2009 Feb 13;5(4):443–451. doi: 10.1016/j.nano.2009.01.015

Figure 3.

Figure 3

Comparative study of cytotoxicity in raw and purified emulsions prepared with different surfactants tested against MRSA (ATCC 43300) and S. aureus (ATCC 25923) by MIC in broth with 3% of drug (β-lactam 10). (1) 7% Tween 20 and 1% KPS, pH 3.6, raw (blue) and purified (pink), (2) 3% cationic surfactant without drug, raw (blue) and purified (pink), (3) 5% cationic surfactant without drug, raw (blue) and purified (pink), (4) 7% cationic surfmer (hydroxy) without drug, raw (blue) and purified (pink), (5) 3% zwitterionic surfactant without drug, raw (blue) and purified (pink), (6) 3% anionic surfmer with β-lactam 49, raw (blue) and purified (pink), (7) 7% non-ionic valeric surfactant, 1% KPS, with β-lactam 10, raw (blue) and purified (pink), (8) 3% zwitterionic surfactant with β-lactam, raw (blue) and purified (pink), (9) 50% Pluronic F68, (10) 50% Pluronic F 68 with β-lactam 10, raw (blue) and purified (pink).